The research, development, manufacture and marketing of pharmaceutical products (including, but not limited to, APIs (active pharmaceutical ingredients), finished pharmaceutical products, reagents, raw materials, exclusive materials and equipment); the engagement of consultants, contractors and general pharmaceutical service providers, national or international; and the development of business opportunities in the field of pharmaceutical biotechnology, biological products and innovative therapies for human health. The company may establish branches and subsidiaries in Switzerland and abroad and may participate in other companies in Switzerland and abroad, excluding participations in non-listed real estate companies. The company may acquire, hold and sell commercial real estate and intellectual property rights. The company may engage in all commercial, financial or other activities that are directly or indirectly related to the company's purpose. The company may grant loans and/or other forms of financing, including those made in the context of cash pooling (if applicable), for consideration or free of charge, to third parties or to companies in which it holds direct or indirect participations, as well as to its direct or indirect shareholders, and to companies in which these shareholders hold direct or indirect participations. The company may also provide any security or guarantee for the security of its obligations or the obligations of each of these persons, including in the form of assignment or transfer as security, pledge, guarantee of any kind or indemnification undertaking, for consideration or free of charge. The company may grant these financings, securities or guarantees even if they are granted in the exclusive interest of third parties or companies in which the company holds a direct or indirect interest, as well as to its direct or indirect shareholders and to companies in which these shareholders hold a direct or indirect interest.
Outbound Leads by COHAGA